文献速递基础与转化研究临床试验与 GCP

胆固醇通过减弱孕激素信号传导使子宫内膜癌对孕激素治疗脱敏

Cholesterol desensitizes the response of endometrial cancer to progestin by attenuating progestin signaling.
PubMed 文献 · Sci Transl Med · 2025-10-01

该研究分析血清脂质差异发现,孕激素抵抗的子宫内膜癌(EC)/子宫内膜不典型增生(EAH)患者血清载脂蛋白A-I降低且内膜组织胆固醇蓄积增加。机制上细胞胆固醇与孕激素竞争结合孕激素受体B(PRB),损害其磷酸化、核转位及下游基因激活。瑞舒伐他汀钙降脂治疗在动物模型及单臂开放标签2期临床试验中恢复孕激素敏感性,提示胆固醇蓄积参与孕激素抵抗,孕激素联合他汀可能增强EC疗效。

要点

  • 孕激素抵抗的EC/EAH患者血清载脂蛋白A-I降低、内膜组织胆固醇蓄积增加
  • 细胞胆固醇竞争性结合PRB,干扰孕激素信号传导
  • 瑞舒伐他汀钙在动物模型及单臂开放标签2期试验中恢复孕激素敏感性

核心结论

  • 胆固醇蓄积参与孕激素抵抗,孕激素联合他汀可能增强EC治疗疗效。

研究设计与样本

  • 研究包括血清脂质差异分析、分子对接模拟、细胞模型、动物模型及单臂开放标签2期临床试验。

主要发现

  • 孕激素抵抗的EC/EAH患者血清载脂蛋白A-I浓度降低且子宫内膜组织胆固醇蓄积增加。
  • 细胞胆固醇与孕激素竞争结合PRB,损害PRB磷酸化、核转位及下游基因激活。
  • PRB中亮氨酸887被丙氨酸887替换可破坏胆固醇结合但保留孕激素反应性。
  • 瑞舒伐他汀钙降脂治疗在动物模型和单臂开放标签2期临床试验中恢复孕激素敏感性。

关键数值与推荐

  • 孕激素抵抗的EC/EAH患者血清载脂蛋白A-I浓度降低且内膜组织胆固醇蓄积增加。
  • PRB亮氨酸887替换为丙氨酸887破坏胆固醇结合并保留孕激素反应性。

临床怎么用

  • 作者认为孕激素联合他汀可能增强EC治疗疗效。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Progestin is the primary fertility-preserving treatment for patients with endometrial cancer (EC) and its precursor lesions, endometrial atypical hyperplasia (EAH); however, a subset of patients exhibits a poor response. In this study, through the analysis of serum lipid differences, we found that progestin-resistant patients with EC/EAH exhibited reduced serum apolipoprotein A-I concentrations and increased cholesterol accumulation in endometrial tissue. Mechanistically, molecular docking simulations and cellular models confirmed that cellular cholesterol interfered with progestin-driven signaling by competing with progestin for binding to progesterone receptor B (PRB), thereby impairing its phosphorylation, nuclear translocation, and downstream gene activation. Substitution of leucine887 with alanine887 in PRB disrupted cholesterol binding but preserved progestin responsiveness. Furthermore, cholesterol-lowering therapy with rosuvastatin calcium restored progestin sensitivity in animal models and in a single-arm, open-label phase 2 clinical trial. Our work shows that cholesterol accumulation contributes to progestin resistance and that combining progestin with statins may enhance therapeutic efficacy in EC.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. Hu J, Wang L, Yang B, et al. Cholesterol desensitizes the response of endometrial cancer to progestin by attenuating progestin signaling. Sci Transl Med. 2025. PMID: 41032624. doi:10.1126/scitranslmed.adp0064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。